The Division of Hematology’s major academic goal is to promote the understanding of a wide scope of hematological diseases. The diagnosis and management of these diseases require a broadly based knowledge in bone marrow physiology and biochemistry, tumor cell growth, hemostasis and thrombosis, red blood cell and hemoglobin molecular biology, and immunology. The division has developed good collaboration with the departments of Pathology and Laboratory Medicine and Integrative Biology and Pharmacology in the Medical School and M. D. Anderson Cancer Center. The interactions enhance research, teaching, and patient activities.

The division provides both inpatient and ambulatory care services. It provides consultation services at Memorial Hermann and LBJ hospitals and M. D. Anderson Cancer Center.

The Gulf States Hemophilia Diagnostic and Treatment Center is operated under the direction of this division. The Special Hemostasis Laboratory performs platelet aggregation and adhesiveness studies, clotting factor and complement component assays, and platelet antibody tests.

The division has developed strong, cohesive NIH-supported research programs focusing on cell and molecular biology of prostaglandin and nitric oxide synthase and protein chemistry and structure biology of synthetic enzymes. These basic investigations have greatly enhanced the understanding of endothelial cell and blood cell functions. The research program has been recognized nationally as a center of excellence. The division houses the Central Hemostasis Laboratory of the ARIC study sponsored by the National Heart, Lung and Blood Institute of NIH. This laboratory has contributed significantly to the hemostatic and genetic risk factors of arterial and venous thrombosis.

The division works closely with the Vascular Biology Research Center at the Medical School and the Institute of Molecular Medicine in research and training programs.

  UTHSC-H General .pdf